trending Market Intelligence /marketintelligence/en/news-insights/trending/-QJfzIqhLd0cFJlmRNvdGg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Macrocure completes merger with Leap Therapeutics unit


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Macrocure completes merger with Leap Therapeutics unit

Macrocure Ltd. completed its merger with a unit of Cambridge, Mass.-based Leap Therapeutics Inc.

Shareholders of Macrocure will receive 0.1815 common share of Leap per ordinary share of Macrocure canceled, plus cash in place of a fractional common share of Leap.

Trading of Macrocure shares on the Nasdaq Global Market has ceased, and the trading of Leap common stock on the same exchange will begin Jan. 24.